Epizyme (EPZM) PT Lowered to $10 at Morgan Stanley
Get Alerts EPZM Hot Sheet
Price: $1.47 --0%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on Epizyme (NASDAQ: EPZM) to $10.00 (from $11.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Nippon Life India Asset Management Ltd (NAM:IN) PT Raised to INR610 at Kotak
- Hindustan Unilever Ltd (HUVR:IN) PT Lowered to INR2,530 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!